We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
3rik
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 3rik is ON HOLD | + | The entry 3rik is ON HOLD until Paper Publication |
Authors: Orwig, S.D., Lieberman, R.L. | Authors: Orwig, S.D., Lieberman, R.L. | ||
Description: The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease | Description: The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease | ||
Revision as of 16:15, 22 June 2011
Unreleased structure
The entry 3rik is ON HOLD until Paper Publication
Authors: Orwig, S.D., Lieberman, R.L.
Description: The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease
